Osmosis Investment Management UK Ltd Makes New Investment in Cigna Group $CI

Posted by Geri Gentry on Aug 24th, 2026

Osmosis Investment Management UK Ltd bought a new position in Cigna Group (NYSE:CI – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 26,243 shares of the health services provider’s stock, valued at approximately $7,235,000.

Other institutional investors have also modified their holdings of the company. Assetmark Inc. boosted its holdings in Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after purchasing an additional 5,963 shares during the period. Mystic Asset Management Inc. acquired a new position in shares of Cigna Group in the 2nd quarter valued at about $2,808,000. HighTower Advisors LLC grew its position in shares of Cigna Group by 402.7% during the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after buying an additional 283,897 shares during the last quarter. KBC Group NV lifted its holdings in Cigna Group by 6.4% in the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after acquiring an additional 22,978 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its stake in Cigna Group by 12.1% in the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock valued at $22,833,000 after acquiring an additional 8,960 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In related news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 23,012 shares of company stock valued at $6,386,550 in the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $276.19 on Monday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The business has a 50 day simple moving average of $284.20 and a 200 day simple moving average of $281.45.

Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the business earned $7.20 EPS. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is currently 25.82%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CI shares. Piper Sandler reduced their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Robert W. Baird set a $362.00 target price on Cigna Group in a research note on Friday, July 31st. The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Wells Fargo & Company upped their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, UBS Group increased their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Check Out Our Latest Report on Cigna Group

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.